Intratympanic dexamethasone as a symptomatic treatment for Ménière's disease.


OBJECTIVE Determine whether intratympanic (IT) dexamethasone, when given on an as needed basis, can successfully control Ménière's disease (MD) symptoms in a large percentage of patients and allow them to avoid ablative therapies. STUDY DESIGN Retrospective chart review. SETTING Tertiary medical center. PATIENTS One hundred fifty-nine patients met the… (More)
DOI: 10.1097/MAO.0000000000000500


Cite this paper

@article{McRackan2014IntratympanicDA, title={Intratympanic dexamethasone as a symptomatic treatment for M{\'e}ni{\`e}re's disease.}, author={Theodore R. McRackan and Jennifer Best and Elizabeth C Pearce and Marc L. Bennett and Mary S. Dietrich and George B. Wanna and David S. Haynes and Robert F. Labadie}, journal={Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology}, year={2014}, volume={35 9}, pages={1638-40} }